OR2H2 and atherosclerosis: Furthermore, gene knockout of Olfr2 or the use of its antagonist, such as citral, significantly reduced the formation of atherosclerotic plaques, indicating that olfactory receptors may serve as potential targets for the prevention and treatment of atherosclerosis [34].